A detailed history of Private Portfolio Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Private Portfolio Partners LLC holds 2,572 shares of ABT stock, worth $302,878. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,572
Holding current value
$302,878
% of portfolio
0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $257,380 - $303,830
2,572 New
2,572 $293,000
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $328 - $362
3 Added 0.11%
2,619 $297,000
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $1,082 - $1,324
12 Added 0.46%
2,616 $287,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $16,335 - $19,600
171 Added 7.03%
2,604 $252,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $4,131 - $4,603
41 Added 1.71%
2,433 $265,000
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $9,395 - $11,058
-97 Reduced 3.9%
2,392 $242,000
Q4 2022

Feb 01, 2023

BUY
$95.06 - $111.52 $190 - $223
2 Added 0.08%
2,489 $273,000
Q3 2022

Mar 14, 2023

SELL
$96.76 - $112.03 $137,012 - $158,634
-1,416 Reduced 36.29%
2,486 $240,000
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $137,012 - $158,634
-1,416 Reduced 36.28%
2,487 $241,000
Q2 2022

Mar 14, 2023

BUY
$102.07 - $123.37 $204 - $246
2 Added 0.05%
3,902 $423,000
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $306 - $370
3 Added 0.08%
3,903 $424,000
Q1 2022

Mar 14, 2023

BUY
$114.02 - $139.04 $228 - $278
2 Added 0.05%
3,900 $461,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $228 - $278
2 Added 0.05%
3,900 $462,000
Q4 2021

Mar 14, 2023

SELL
$115.53 - $141.46 $9,820 - $12,024
-85 Reduced 2.13%
3,898 $548,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $9,935 - $12,165
-86 Reduced 2.16%
3,898 $549,000
Q3 2021

Mar 14, 2023

BUY
$116.66 - $129.06 $185,372 - $205,076
1,589 Added 66.37%
3,983 $470,000
Q3 2021

Nov 04, 2021

BUY
$116.66 - $129.06 $185,372 - $205,076
1,589 Added 66.35%
3,984 $471,000
Q2 2021

Mar 14, 2023

SELL
$105.79 - $124.53 $13,329 - $15,690
-126 Reduced 5.0%
2,394 $277,000
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $13,329 - $15,690
-126 Reduced 5.0%
2,395 $278,000
Q1 2021

Mar 14, 2023

SELL
$108.84 - $128.23 $28,951 - $34,109
-266 Reduced 9.55%
2,520 $301,000
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $28,842 - $33,980
-265 Reduced 9.51%
2,521 $302,000
Q4 2020

Mar 14, 2023

BUY
$105.0 - $114.42 $210 - $228
2 Added 0.07%
2,786 $305,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $210 - $228
2 Added 0.07%
2,786 $305,000
Q3 2020

Mar 14, 2023

BUY
$91.64 - $111.29 $27,033 - $32,830
295 Added 11.85%
2,784 $302,000
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $19,061 - $23,148
-208 Reduced 6.95%
2,784 $303,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $601,074 - $769,300
-7,850 Reduced 72.4%
2,992 $274,000
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $12,375 - $18,096
197 Added 1.85%
10,842 $855,000
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $1,648 - $1,835
21 Added 0.2%
10,645 $924,000
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $6,138 - $6,655
75 Added 0.71%
10,624 $889,000
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $768,811 - $896,665
10,549 New
10,549 $887,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Private Portfolio Partners LLC Portfolio

Follow Private Portfolio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.